MedTrace Logo

Body Constitution Classification Based Comprehensive Health Management Intervention on Obese Population

NCT02298426 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1452

Last updated 2017-04-06

No results posted yet for this study

Summary

This study aims to explore the effectiveness of body constitution classification based comprehensive health management intervention on obese population.

Conditions

Interventions

BEHAVIORAL

Health Management

We provide large scales of weight management information included recipes according to people's constitution. Information is provide through both face to face meeting and telephones. Materials are also given to participants.

BEHAVIORAL

General Management

We provide general information about health. Information is provided through telephones and materials.

OTHER

Placebo

We use placebo to replace the health product.

DIETARY_SUPPLEMENT

SCHSANDRA PLUS, YI RUI CAPSULE, Gest Aid Plus: INFINITUS®

We use dietary supplement products to help balance the constitution of participants. Each participant got one of the three dietary supplement products. SCHSANDRA PLUS, INFINITUS® is a health product made of Schisandra, ginseng, Ginseng, Radix and other plant materials which can help enhance the body's antioxidant capacity. YI RUI CAPSULE , INFINITUS® is a health product made of salvia, hawthorn, alisma, perilla oil microcapsules, panax powder, ginkgo biloba and other plant materials which can assist lower the blood lipid level. Gest Aid Plus, INFINITUS® is a health product made of yam, codonopsis, poria, white beans, dried tangerine peel and other plant materials which can help regulate intestinal flora.

Sponsors & Collaborators

  • Hai-Jun Wang

    lead OTHER

Principal Investigators

  • Jun Ma · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-05-31
Completion
2015-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02298426 on ClinicalTrials.gov